Sartorius Reports Nine-Month Results, Confirms Full-Year Outlook
Sartorius said revenue and earnings grew in the first nine months of 2026, exceeding expectations, and confirmed full-year guidance for the group and Bioprocess Solutions division. Third-quarter results were slightly below some expectations.